Difluoromethylornithine, an effective new treatment of gambian trypanosomiasis

This publication has 18 references indexed in Scilit:

• New Drug Combination for Experimental Late-Stage African Trypanosomiasis: DL-α-Difluoromethylornithine (DFMO) with Suramin
  The American Journal of Tropical Medicine and Hygiene, 1984
• Chemotherapeutic implications of polyamine biosynthesis inhibition
  Clinical Pharmacology & Therapeutics, 1984
• In vivo effects of α-dl-Difluoromethylornithine on the metabolism and morphology of Trypanosoma brucei brucei
  Molecular and Biochemical Parasitology, 1983
• Polyamine metabolism and function
  American Journal of Physiology-Cell Physiology, 1982
• Novel combination chemotherapy of experimental trypanosomiasis by using bleomycin and DL-α-difluoromethylornithine; reversal by polyamines
  Biochemical Pharmacology, 1982
• A ‘healthy’ carrier of African trypanosomiasis
  Journal of Infection, 1982
• Content, Synthesis, and Function of Polyamines in Trypanosomatids: Relationship to Chemotherapy1^,2
  The Journal of Protozoology, 1981
• Present status of chemotherapy and chemoprohylaxis of human trypanosomiasis in the Eastern Hemisphere
  Pharmacology & Therapeutics, 1980
• Polyamine Metabolism: A Potential Therapeutic Target in Trypanosomes
  Science, 1980
• Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs
  Journal of the American Chemical Society, 1978